Volitionrx announces internal clinical study for Nucleosomics diagnostic products
VolitionRx Limited, announces that it will commence a large internal clinical study for its Nucleosomics diagnostic products this month.
Incyte Corporation announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: